← Open Payments lookup

MICHAEL LAPINSKI: Open Payments

NPI 1902505639 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$724 in 38 payments from 9 companies in 2025. Trend: 2023 $40 · 2024 $641 · 2025 $724

Food & beverage: $724
CompanyPaymentsAmount
ABBVIE INC.11$199
Otsuka America Pharmaceutical, Inc.11$148
Alkermes, Inc.5$104
Axsome Therapeutics, Inc.3$88
Neurocrine BioSciences, Inc.3$71
Vanda Pharmaceuticals Inc.2$44
Teva Pharmaceuticals USA, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Janssen Pharmaceuticals, Inc1$17

Products named: VRAYLAR, REXULTI, Auvelity, ARISTADA, INGREZZA, FANAPT, UZEDY, CAPLYTA.

Industry payments across MA — which companies pay providers there.